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Abstract Despite an influx of T cells to the cervix during HIV infection, genital T cells are not
associated with control of HIV shedding. CD57 expression by T cells has been associated with
enhanced migratory potential and CD57+ T cells have been shown to accumulate in tissues during
the late stages of HIV disease. We investigated the impact of HIV-infection and clinical status on
the expression of CD57 by T cells from the female genital tract in 13 HIV-infected and 5
uninfected women. We found that cervical and blood-derived T cells expressed similar
frequencies of CD57. The frequency of CD57 expression by cervical or blood T cells was not
associated with clinical status (CD4 counts). No impairment in IFN-γ production by CD57+ T cells
from the genital tract was observed. We conclude that increased T cell senescence does not
appear to be a hallmark of genital mucosal HIV-1 infection.
© 2010 Elsevier Inc. Open access under CC BY license.of Infectious Diseases and
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4066681.
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Women infected with HIV-1 are significantly more suscepti-
ble to bacterial vaginosis and sexually transmitted infections
than uninfected women [1–3] suggesting that local immunity
in the genital tract is compromised during HIV infection. HIV-
infected women have both significantly elevated concentra-
tions of genital tract inflammatory cytokines and cellular
recruitment than uninfected women [4]. Despite thegeneralized influx into the genital mucosa of HIV-specific
cytotoxic T lymphocytes (CTLs) and other immune cells
during HIV infection, HIV-responsive genital T cells are not
associated with local control of HIV shedding [5,6].
In blood, progressive chronic HIV infection has been
associated with terminal differentiation of T cells, increased
expression of CD57 (a marker of senescence), decreased
proliferative capacity and impaired cytolytic activity [7–9].
Effector memory T cells, the most terminally differentiated
T cell subset found in the blood [7,10], are also the
predominant subset of T cells found at the cervix of both
HIV-infected and uninfected women [4]. CD57+ T cells have
been shown to have enhanced migratory potential [10] and
accumulate in lung mucosal tissue during the late stages of
HIV disease [11]. We hypothesize that an impairment of
138 L.J. Liebenberg et al.mucosal T cell function associated with increased senes-
cence (marked by CD57 expression) may contribute to the
inability of T cells in the genital mucosa to control HIV
locally. The aim of this study was to determine whether CD57
expression by T cells in the female genital tract was
associated with genital mucosal HIV-1 infection.
Methods
Thirteen HIV-1 subtype C infected and five uninfected
women were recruited for this study. HIV-infected women
had CD4 counts N300 cells/µl. Women who were menstru-
ating at the time of sampling, were post-menopausal, had
undergone a hysterectomy, had visible or reported STI were
excluded from the study. The study was approved by the
University of Cape Town (South Africa) Research Ethics
Committee and informed written consent was obtained from
all volunteers before the study was initiated.
Collection and processing of cervical specimens
and blood
A cervical cytobrush was taken from women under speculum
examination. Cervical mucosal mononuclear cells (MMCs)
were collected as previously described [4,5] by inserting a
Digene cervical sampler into the endocervical os, rotating
360° and placing the cytobrush in 3 ml transport media
[RPMI1640 supplemented with 5 mM glutamine, fungazone,
penicillin, streptomycin and 10 % fetal calf serum (FCS)].
Samples with visible blood contamination were discarded.
Cells were processed within 4 h of collection by flushing the
cytobrush ∼30 times with the same 3 ml transport media.
The cell suspension was then transferred to a clean 15 ml
tube and centrifuged at 2300 rpm (1000×g) for 10 min. The
pelleted cells were resuspended in R10 prior to processing
both for counting and phenotyping using an automated
Guava cell counter (Guava technologies, Hayward, CA), and
for functional analysis by flow cytometry (LSRII, Becton
Dickinson (BD) Biosciences, San Jose, CA). Isolated mucosal T
cells were quantified with the phenotypic marker, CD3-PE (T
cells; Guava technologies) using a Guava Automated Cell
counter (described in detail by Nkwanyana et al. [4]).
Briefly, cells (25 μl/tube) were stained with pre-titrated
anti-CD3-PE and incubated at 4 °C for 30 min. Cells were
washed with 1 ml wash buffer (1% FCS PBS) and centrifuged
at 1500 rpm (437×g) for 5 min. The supernatant was
discarded and a volume of 200 µl Cell Fix (BD Biosciences)
was added to each tube. Samples were acquired and
analyzed using Cytosoft® software (Guava technologies). At
least 2000 events were captured per analysis. Peripheral
blood mononuclear cells (PBMCs) were isolated from ACD-
anticoagulated whole blood using Ficoll-Hypaque density
gradient centrifugation.
Flow cytometry and intracellular cytokine staining
PBMCs (1×106 cell/ml) or MMCs (∼0.15-1×106 cell/ml)
were stimulated with (i) HIV subtype C (Du422) Gag
overlapping peptides (121 15-mer peptides overlapping by
10-amino acids; each peptide was used at a final concen-
tration 1 μg/ml; peptides were kindly provided by the NIHAIDS Reagent Repository); (ii) PMA/ionomycin (each at a
concentration of 10 μg/ml; Sigma-Aldrich; positive control);
or (iii) untreated for 6 h at 37 °C and 5% CO2. Brefeldin A
(10 μg/ml; Sigma, St. Louis, MO) was added after the first
hour. The cells were washed in 10% FCS PBS containing
0.01% NaN3 (staining buffer) for 5 min at 300×g before
staining with anti-CD3, CD57, CD4 and CD8 antibodies
(Becton-Dickinson, San Jose, CA) for 30 min on ice. Cells
were washed as before, were fixed and permeabilized
(CytoFix/CytoPerm; BD), and washed with 0.1% Saponin
(Fluka) in staining buffer. Cells were stained with anti-IFN-γ
antibody (BD) for 1 h at 4 °C, were washed and then fixed
with Cell Fix (BD). Fluorescence was measured using a
FACSCalibur Flow Cytometer (BD Immunocytometry Systems
[BDIS]) and FlowJo (Tree Star, Inc.) was used for analysis
and compensation. From cytobrush samples, the median
number of CD3+ events captured for flow cytometry was
1640 (range 100–10091).
For evaluation of surface expression of CD57, CD28, CD95
and CD38 expression by cervical and blood-derived T cells,
an 8-colour panel including CD3, CD4, CD8, Vivid, CD57,
CD28, CD95 and CD38 antibodies (Becton-Dickinson, San
Jose, CA) was used. Cells were washed in 10% FCS PBS
containing 0.01% NaN3 (staining buffer) for 5 min at 300×g
before staining with surface antibodies (Becton-Dickinson,
San Jose, CA) for 30 min on ice. Cells were washed as
before, and then fixed with Cell Fix (BD). Fluorescence was
measured using a LSRII Flow Cytometer (BD Immunocyto-
metry Systems [BDIS]) and FlowJo (Tree Star, Inc.) was used
for analysis and compensation. Fluorescence minus one was
used to define gates.
Measurement of viral load in cervical secretions
Viral load was determined in cervical secretions (derived
from the cytobrush wash fraction) using Nuclisens Easyq
HIV 1 Version 1.2. The detection limit of this assay was
50 copies/ml.
Measurement of cytokine concentrations in genital
secretions
Concentrations of inflammatory IL-1β, IL-6, and IL-8 and
TNF-α in cervical supernatants were determined using
Quantikine high sensitivity ELISA kits (R&D Systems Inc.,
Minneapolis, MN) according to manufacturer's instructions.
The limit of detection of IL-1β, IL-6, IL-8 and TNF-α assays
ranged between 0.6 and 1 pg/ml. Cytokine values below the
assay's limit of detection were reported as zero.
Statistical analysis
For parametric data, the paired Student's t-test was used for
matched comparisons, unpaired Student's t-test was used for
unmatched comparisons and Pearson's correlation test was
used to test the association between variables using
GraphPad Prism 5.0® (San Diego, CA). For non-parametric
data, a Wilcoxon test was used for matched comparisons and
the Spearman rank test was used to test associations. Chi-
squared tests were used to compare binomial data. P-values
≤0.05 were considered significant.
139Genital tract CD57 expression and HIV infectionResults
Thirteen women chronically infected with HIV-1 were
recruited into our study to investigate the frequency
and functional ability of CD57+ T cells in the genital tract
(Table 1). Five age-matched healthy uninfected women from
the same community were recruited as controls. HIV-
infected women had a median CD4 cell count of 394 cells/
μl (IQR 324-558) and median plasma viral load of 8250
copies/μl (IQR 4425-40500).
Cervical T cells were isolated from both HIV-infected and
uninfected women by cytobrush with a single cytobrush
yielding a median of 92160 CD3+ T cells (IQR 84704-93900)
from HIV- women and 71456 CD3+ cells (IQR 32160-113872)
from HIV+ women (Table 1). Although the yield of CD3+ T
cells did not differ significantly between groups, HIV-
infected women had a significantly skewed CD4:CD8 ratio
compared to uninfected women (0.3:1 in HIV+ compared to
1.8:1 in HIV−; p=0.0002; unpaired t-test) indicating that
HIV+ women in general had fewer cervical CD4+ T cells than
HIV− women (Table 1).
Of the HIV-infected women studied, 7/13 (53.8%) had
detectable HIV RNA in their cervical secretions indicating
that they were shedding virus (Table 1). Of the 7 women
found to be shedding HIV, their median genital tract HIV load
was 350 RNA copies/ml of cervical secretion (IQR 280-2450).
Comparison of CD57 expression by CD4 and CD8 T
cells at the cervix and in blood
The frequency of CD57 expression on CD8 and CD4 T cells
present at the cervix of HIV-infected and uninfected women
was compared to frequencies detected in peripheral blood
(Fig. 1). A representative plot showing CD57 expression by
CD8 and CD4 T cells from blood and cervix is shown in Figure
1A. HIV-infected and uninfected women had similar frequen-
cies of CD8+ T cells expressing CD57 irrespective of
compartment (Fig. 1B). CD4+ T cells expressed significantly
less CD57 both in blood and at the cervix than CD8+ T cells
(pb0.0001 in blood and p=0.002 at the cervix) and the
frequency of CD57 expression by CD4+ T cells was similar
irrespective of HIV status (Fig. 1B). In addition, we observedTable 1 Clinical details of the women included in the study.
Characteristic HI
N 5
Age 36
Duration of infection [years; median (IQR)] na
CD4 count [cell/μl; median (IQR)] na
Plasma HIV load [copies/μl; median (IQR)] na
Number of women shedding HIV in the genital
tract [N/Total (%)]
na
Genital tract viral load [copies/μl; median (IQR)] na
Macroscopic findings [N/Total (%)] ⁎⁎ 0/
Cervical CD3 yield 92
Cervical CD4:CD8 ratio 1.
⁎ p=0.0002.
⁎⁎ Macroscopic findings include vaginal discharge, candidiasis, genital
under speculum examination.no difference in the frequency of CD57 expression by T cells
isolated from the cervix and blood irrespective of HIV status
(Fig. 1B). We found a significant correlation between the
frequency of CD57 expressing CD8+ T cells in blood and at the
cervix indicating a relatedness between the compartments
(R=0.48; p=0.04) although this was not the case for CD4+
cells (Fig. 1C).
Relationship between CD57 expression frequencies
and clinical status (CD4 counts)
We compared the frequency of CD57 expression by cervical
and blood T cells with markers of HIV disease status (blood
CD4 counts). HIV-infected women with N500 CD4+ T cells/
ml had similar frequencies of CD57 expression by CD8+ and
CD4+ T cells in blood as women with b500 CD4 cells/ml
(Table 2). In contrast, HIV-infected women with better CD4+
counts had 1.6-fold lower frequencies of CD57+ CD8 T cells
at the cervix than women with CD4 counts b500 cells/μl
(although this was not significant; p=0.6). We have
previously shown that the CD4:CD8 ratio of genital tract-
derived T cells correlate significantly with blood CD4 counts
[4] and confirm this in the present study (p=0.04; Pearson
R=0.48). We observed no correlation, however, between
cervical CD57 expression and the cervical CD4:CD8 ratio
(data not shown).
Association between CD57 expression and other
markers of senescence or activation
We evaluated expression of other markers of T cell
activation/senescence (CD28, CD95 and CD38) by CD57+ T
cells derived from the cervix and blood (Fig. 2). Figure 2A
shows representative plots of CD8+ T cells from the cervix
(upper panels) and blood (lower panels) co-expressing CD57
with CD95, CD28 or CD38 in HIV-infected women. We
observed a significant positive correlation between surface
expression of CD57 and CD95 by both blood and cervical T
cells (Fig. 2B; Rho=0.78, p=0.01 for blood and Rho=0.76,
p=0.01 for cervix). Similarly, we found a significant
association between expression of CD57 and lack of
expression of CD28 (CD28−; Rho=0.88, p=0.002 for bloodV− HIV+
13
(34–48) 34 (29–37)
7.0 (5.6–7.5)
394 (324–558)
8250 (4425–40,500)
7/13 (53.8)
350 (280–2450)
5 (0) 1/13 (7.7)
,160 (84,704–93,900) 71,456 (32,160–113,872)
8 (1.1–2.2) 0.3 (0.2–0.4) ⁎
ulcers, genital warts or any macroscopically visible findings of note
140 L.J. Liebenberg et al.and Rho=0.79, p=0.009 for the cervix) indicating that
expression of CD28 and CD57 was largely mutually exclusive.
Finally, the marker of activation CD38 was predominantly
expressed by CD57- T cells and these markers were
significantly negatively correlated (Rho=−0.78, p=0.01 for
blood and Rho=−0.59, p=0.08 for the cervix). These data
indicate that, irrespective of compartment, the majority of
CD57+ T cells (65-99%) co-expressed the apoptotic marker
CD95 (FasL). T cells expressing the co-stimulatory moleculeFigure 1 Expression of CD57 by CD8+ and CD4+ T cells derived
from the cervix and blood of HIV+ and HIV− women. (A)
Representative plots showing the frequency of CD57 expression
by blood (left panels) and cervical (right panel) CD8+CD3+ (top
panels) and CD4+CD3+ (lower panels) T cells. (B) We compared
the frequency of CD57+ expression by CD8+CD3+ (upper panel)
and CD4+CD3+ (lower panel) T cells in blood and cervical T cells
from HIV− (n=5) and HIV+ (n=13) women. Each dot represents
an individual woman's CD57 frequency and lines joining dots
indicate matched blood and cervical frequencies in individual
woman. Paired Student's t-test was used to compare CD57
expression frequencies in blood and at the cervix. An unpaired
Student's t-test was used to compare CD57 expression frequen-
cies in HIV+ and HIV− women. (C) Association between the
frequency of CD57 expression by cervical and blood-derived
CD8+CD3+ (left panel) and CD4+CD3+ (right panel) T cells.
Regression lines and Pearson R-values are shown for correla-
tions. p-values ≤0.05 were considered significant.CD28, associated with less terminally-differentiated T cell
subsets, were not likely to co-express CD57 in both the cervix
and blood.
Comparison of CD57+ versus CD57- function by
cervical and blood T cells in response to stimulation
with PMA/ionomycin
To assess the relationship between IFN-γ production and
CD57 expression in the blood and cervix, CD57+ and CD57−
blood- and cervix-derived T cells from chronically HIV-
infected women were assessed by flow cytometry for IFN-γ
responses following stimulation with PMA/ionomycin (Fig. 3).
Figure 3A shows representative plots of IFN-γ production by
CD57+ and CD57− CD8+ T cells from the cervix and blood. In
blood and at the cervix of HIV-infected women, signifi-
cantly higher frequencies of CD57+CD8+ T cells produced
IFN-γ than CD57-CD8+ T cells (p=0.006 for blood and
p=0.03 for cervical samples; Fig. 3B). This trend was also
observed in uninfected women although this was not
significant.
Similarly, in the CD4+ T cell population (Fig. 3C),
significantly higher frequencies of CD57+ cells produced
IFN-γ than CD57- cells (p=0.006 for HIV+ blood and p=0.008
for HIV+ cervical samples). There was also a trend towards
higher frequencies of IFN-γ production by CD57+ cells than
CD57− cells in the blood and cervix from uninfected women
but this was not significant.
Comparison of CD57+ versus CD57− function by
cervical and blood T cells in response to stimulation
with HIV Gag peptides
CD57+ and CD57− blood- and cervix-derived T cells from
chronically HIV-infected women were assessed for IFN-γ
responses following stimulation with HIV-1 subtype C Gag
peptides (Fig. 4). While 9/13 (69.2%) of the HIV-infected
women studied had detectable HIV-specific responses in
blood, only 6/13 (46.2%) had matching responses detected at
the cervix (p=0.2, Chi-squared test). The frequency of IFN-γ
positive cells in these 6 women who did have cervical T cell
Table 2 Impact of HIV clinical status (CD4 counts) on CD57 expression in blood and at the cervix.
Subset Compartment Percentage CD57 expression [median (IQR)] p-value
b500 CD4 cells/μl (n=9) N500 CD4 cells/μl (n=4)
CD8 Blood
Cervix
45.9 (24.9–63.1)
48.9 (15.7–52.1)
41.2 (33.2–50.3)
29.7 (19.7–41.7)
0.9
0.6
CD4 Blood
Cervix
5.9 (3.9–16.5)
8.5 (1.9–34.8)
5.8 (2.4–28.6)
19.5 (11.8–40.8)
0.8
0.5
141Genital tract CD57 expression and HIV infectionresponses was significantly higher than the frequency of
responses detected in matching blood samples (p=0.03). In
women with HIV Gag-specific responses in both blood (upper
panels in Fig. 4) and at the cervix (lower panels in Fig. 4),
IFN-γ production was detected in both CD57+ CD8+ (Fig. 4A)Figure 2 Comparison of CD95, CD28 and CD38 expression by CD57+
plots showing the frequency of CD57 expression by cervical (top pane
(left panels), CD28 (middle panels) or CD38 (right panels). (B) Associ
panels) and blood-derived (bottom panels) T cells and CD95 expressi
and CD38 expression (right panels). Regression lines and Spearma
considered significant.and CD57− CD8+ T cells (Fig. 4B) indicating that both subsets
were contributing to Gag-specific immunity. In the genital
tract, however, we found that the frequency of Gag-specific
IFN-γ responses was significantly higher in CD57+ cells than
CD57− cells (p=0.04). We observed a significant positiveT cells in the female genital tract and blood. (A) Representative
ls) and blood (right panel) CD8+CD3+ T cells co-expressing CD95
ation between the frequency of CD57 expression by cervical (top
on (left panels), lack of CD28 expression (CD28−; middle panels)
n Rho-values are shown for correlations. p-values ≤0.05 were
142 L.J. Liebenberg et al.association between the net frequencies of IFN-γ producing
CD57+ and CD57− cells within each compartment (Fig. 4C;
Spearman R=0.67 and p=0.01 in blood; R=0.54 and
p=0.0005 at the cervix).Association between genital tract inflammation, HIV
shedding and CD57 expression
We compared the concentrations of inflammatory cytokines
IL-6, IL-8, IL-1β and TNF-α in genital secretions from women
infected with HIV and those who were not (Table 3). HIV-
infected women had significantly elevated genital tract
concentrations of IL-6, IL-8 and IL-1β than uninfected
women. However, we observed no association between
genital inflammatory cytokine concentrations and the
frequency of CD57 expression by cervical T cells (Table 3).
HIV RNA was detected in the cervical secretions from 7/13
(53.8%) of HIV-infected women studied indicating that they
were shedding virus (Table 1). We found that HIV-infected
women shedding HIV had similar concentrations of inflam-
matory cytokines in genital secretions compared to women
who were not shedding (Table 4). Since we found a range of
CD57 expression frequencies at the cervix of HIV-infected
women (ranging from 14.2% to 100%), we investigated
whether the extent of T cell exhaustion in the female
genital tract was associated with HIV genital shedding (Table
4). We found no significant difference in the frequency of
CD57 expression by cervical CD8+ T cells from HIV shedders
versus non-shedders (median of 21.1% CD57+ for shedders
compared to 33.3% for non-shedders; p=1.0). In contrast,
cervical CD4+ T cells from women shedding HIV had ∼2.5-
fold higher frequencies of CD57 expression than women not
shedding although this was not significant (median of 20.1%
CD57+ for shedders compared to 8.4% for non-shedders;
p=0.2).
Discussion
In the genital tract, we and others have previously shown
that the presence of HIV-specific T cells was not associated
with local control of HIV shedding [5,6]. CD57 has been
identified as a marker of replicative senescence and
impaired cytolytic function by T cells during chronic HIVFigure 3 Comparison of ex vivo IFN-γ production by CD57+ and
CD57− T cells derived from the blood and genital mucosa of HIV−
and HIV+ women in response to polyclonal stimulation (PMA/
ionomycin). (A) Representative plots showing the frequency of
IFN-γ production by CD57+ or CD57− CD8+ T cells in the blood
(left panels) and cervix (right panels) following PMA/ionomycin
stimulation. (B) Net percentages of IFN-γ producing CD57+CD8+
and CD57−CD8+ T cells (percentage of stimulated IFN-γ
producing cells minus the percentage of background percentage
of unstimulated cells producing IFN-γ) after ex vivo stimulation
with PMA/ionomycin were compared in cervical mucosa (upper
panel) and blood (lower panel) in HIV− (left panel) and HIV+
(right panel) women. (C) Net percentages of IFN-γ producing
CD57+CD4+ and CD57−CD4+ T cells in cervical mucosa (upper
panel) and blood (lower panel in uninfected (left panel) in HIV−
and HIV+ (right panel) women. Each dot represents an
individual's net percentage of CD57+CD8+ or CD57−CD8+ T
cells producing IFN-γ at the cervix and in blood. p-values ≤0.05
were considered significant. Paired Student's t-test was used to
compare IFN-γ frequencies by CD57+ versus CD57− T cells per
individual.
Figure 4 Comparison of ex vivo IFN-γ production by CD57+ and CD57− T cells derived from blood and the genital mucosa of HIV+ and
HIV− women in response to stimulation with HIV Gag peptides (Du422 Subtype C). (A) Net percentages of CD57+CD8+ T cells in HIV+
women (n=18) producing IFN-γ (percentage stimulated IFN-γ producing cells minus the percentage of unstimulated cells producing
IFN-γ) after ex vivo stimulation with HIV Gag peptides were compared in blood (upper panel) and at the cervical mucosa (lower panel).
(B) Net percentage of CD57−CD8+ T cells from HIV+ women producing IFN-γ in blood (upper panel) and at the cervix (lower panel).
Each bar represents an individual's net percentage IFN-γ producing CD57+CD8+ or CD57−CD8+ T cells at the cervix and in blood. (C)
Association between the net percentages of CD57+CD8+ and CD57−CD8+ cells producing IFN-γ in response to Gag in the blood (upper
panel) and at the cervix (lower panel). Each dot represents an individual woman's net IFN-γ producing CD57+ and CD57− T cell
frequencies in blood and at the cervix. Regression lines and Spearman Rho values are shown for correlations. p-values ≤0.05 were
considered significant. Wilcoxon matched pairs tests were used to compare frequencies of IFN-γ producing CD57+ and CD57− T cells
within and between compartments.
143Genital tract CD57 expression and HIV infectioninfection [7,12–14], and T cells expressing CD57 have also
been shown to accumulate in lung mucosal tissue during the
late stages of disease [11]. Since genital tract infiltrating T
cells have been shown to be predominantly differentiated
effector memory phenotype [4] and since there have been no
published studies of CD57 expression at the female genitalTable 3 Association between genital tract inflammation and CD
Cytokines HIV-infected
median (IQR)
Uninfected
median (IQR
IL-6 (pg/ml) 89.9 (49.4–183.8) 30.4 (5.9–57
IL-8 (pg/ml) 80.7 (23.8–230.3) 25.4 (13.3–2
IL-1β (pg/ml) 68.9 (11.2–172.3) 1.9 (1.3–11
TNF-α (pg/ml) 0.0 (0.0–4.2) 0.0 (0.0–0.
⁎ Pearson correlation.mucosa, we hypothesized that CD57 expression by cervical T
cells may be associated with impaired T cell function
resulting in inability to control local HIV replication.
We first investigated whether CD57+ T cells were more
prevalent in the cervices of HIV-infected women than they
were in uninfected women and then whether CD5757 expression in the female genital tract.
)
p-value Correlation ⁎ with cervical
CD57 expression frequencies
R p-value
.4) 0.02 0.34 0.08
8.6) 0.04 0.24 0.27
.1) 0.004 0.18 0.37
01) 0.4 0.27 0.18
Table 4 Association between HIV shedding, inflammatory cytokine concentrations and CD57 expression in the female genital
tract.
HIV shedders ⁎
median (IQR)
Non-shedders
median (IQR)
p-value
IL-6 (pg/ml) 147.0 (23.4–183.9) 97.3 (40.4–195.7) 0.9
IL-8 (pg/ml) 80.2 (35.4–301.9) 81.3 (13.9–206.4) 0.5
IL-1β (pg/ml) 81.5 (34.4–150.9) 99.9 (7.7–171.0) 0.8
TNF-α (pg/ml) 0.02 (0–29.8) 0 (0–0) 0.2
% CD8+CD57+ 21.1 (10.3–53.0) 33.3 (40.3–48.9) 1.0
% CD4+CD57+ 20.1 (7.4–60.0) 8.4 (5.0–23.1) 0.2
⁎ HIV shedders were defined as any HIV-infected women with HIV RNA copies N50 copies/ml of cervical supernatant.
144 L.J. Liebenberg et al.expression frequencies were associated with markers of
disease progression or decreased T cell function. In blood, we
found no significant difference in the frequencies of CD57+ T
cells in HIV infected and uninfected women. While some
studies have reported higher frequencies of blood CD57
expression associated with HIV infection [10,15–17], others
did not find any difference [11]. At the cervix, similar
frequencies of CD57+ T cells were observed at the cervices of
both HIV− and HIV+ women. Irrespective of the compartment
from which T cells were isolated, we found that the
frequency of CD8+ cells expressing CD57 was significantly
higher than the frequency of CD4+ T cells expressing this
marker. Further, we showed that the frequency of CD57
expression by cervix- and blood-derived CD8+ T cells was
significantly correlated.
Wood et al. [11] found that HIV-infected women with CD4
counts b500 cell/μl had significantly elevated frequencies of
CD57+ T cells at the lung mucosa compared to uninfected
women and HIV+ women with higher CD4 counts (N500 cells/
μl). These earlier studies conducted in the lung were done
using cells isolated from bronchoalveolar lavage [11] which is
comparable to cervical cytobrushing in terms of the depth of
sample collection from mucosal surfaces. We did not observe
any significant association between the frequency of CD57
expression by cervical T cells and clinical status (CD4
counts). The 13 HIV+ women included in the current study
had been infected with HIV for a median of 7 years (IQR 5.6–
7.5 years) with the majority having CD4 counts b500 cells/μl
(64%). It is therefore possible that the differences in CD57
expression at the lung compared to blood [11] may have been
masked in our study by inclusion of women in more advanced
HIV disease. It would be beneficial in the future to focus
analysis on HIV-infected women during early infection where
compartment-specific differences may be more likely. It
would be beneficial in future to focus analysis on HIV-
infected women during early infection where compartment-
specific differences may be more likely. In addition, ∼half of
the HIV+ women studied by Wood et al. [11] were taking anti-
retroviral therapy while none of the 13 HIV+ included in this
study were. Immune reconstitution associated with ART may
be associated with reduced immune exhausting (CD57
expression) and may contribute to the discrepancies ob-
served between our study and the findings reported by Wood
et al. [11].
We found that significantly higher frequencies of CD57+ T
cells in the female genital tract produced IFN-γ than CD57- T
cells, indicating that CD57 expression was not associated
with a decreased capacity to produce IFN-γ. The majority ofcervical T cells derived through cytobrushing are generally
effector memory cells (53% of CD8+CD3+ T cells at the cervix
are CD45RA−CD27−CCR7− effector memory cells [4]) and
effector memory T cells are the most terminally differenti-
ated T cell subset [7,10]. It was therefore surprising that
despite CD57 expression being a marker of terminal
differentiation [7,12–14], the frequency of cervical T cells
expressing CD57 is similar to and significantly correlated with
that observed for cells in blood. It is noteworthy that cervical
cells analyzed in this study, derived from outer epithelial
layers of the genital tract by gentle cytobrushing, may not
reflect the frequency or number of CD57 expressing cells in
genital tissue (from cells derived by tissue biopsy).
Terminally differentiated (CD57+) T cells are preferen-
tially recruited to the lung mucosa during the course of HIV-
infection [11,16]. Relative to CD57- T cells, CD57+ T cells in
blood are known to have increased expression of the
chemokine receptor CX3CR1 and reduced expression fre-
quencies of CCR7 and CD62 ligand [10]. Previous indications
of increased CD8+ CD57+ T cell frequencies in lung tissues are
consistent with CD57 expression predisposing CD8+ T cells to
migrate to tissues rather than to lymphoid organs [19].
We found that CD57+ T cells derived from the cervix and
blood were largely CD95+ indicating their propensity to
undergo apoptosis. We observed similar frequencies of
CD95+ T cells in blood and at the cervix (data not shown)
suggesting the cells in the genital tract were not more prone
to CD95-associated apoptosis than cells from blood. Previous
studies have reported that∼99% of senescent T cells in blood
do not express CD28 and that CD28 expression is associated
with naïve or less differentiated T cells [20]. In support of
this, we found a reciprocal relationship between expression
of CD57 and CD28 by T cells from the cervix and blood
indicating that expression of these markers was mutually
exclusive.
Since CD57 expression is enhanced by chronic antigenic
stimulation in blood [10,15,17,18], we investigated HIV-
specific IFN-γ responses by CD57+ T cells at the genital
mucosa. Although we found no significant differences in the
ability of CD8+CD57+ and CD8+CD57− T cells to secrete IFN-γ
following PMA stimulation, HIV Gag-specific responses were
more readily detected at the cervix for CD8+CD57+ T cells
than they were for CD8+CD57− T cells. The frequencies of
HIV Gag-specific CD8+CD57+ and CD8+CD57− T cells at the
cervix are significantly higher than those in the blood during
chronic HIV infections. This raises questions about both the
effects of compartment-specific antigen loads on HIV-
specific T cell responses, and the migratory capacity and
145Genital tract CD57 expression and HIV infectionpatterns of HIV-specific CD8+CD57+ T cells. Although our
study has measured the ability of T cells to secrete IFN-γ
alone as a surrogate for T cell functional ability, the
functional competence of T cells is better defined by
broader capacity to secretion of additional cytokines and
release perforin (polyfunctionality), direct cytolytic activity
against target cells and, most importantly, the direct ability
to proliferate [21].
This is the first study to investigate CD57 expression of
cervical T cells ex vivo and to investigate the impact of CD57
expression on HIV-specific and mitogen-induced cytokine
function at the cervix. The ability to mount an effective
mucosal cellular immune response to an HIV vaccine is one of
the fundamental prerequisites to providing prophylactic
protection against infection. With increased susceptibility
to opportunistic genital tract infections during HIV infection,
enhanced cellular recruitment to the cervix, and the
association between impaired proliferative capacity and
lytic function of CD57+ T cells, concerns have been raised
about the efficacy of genital tract T cells to control HIV
infection. Since the frequency of CD57 expression by T cells
from the genital tract largely mirrors that of the blood in
chronic HIV infection, we found no obvious evidence of an
association between CD57 expression and impaired cervical T
cell function. We conclude that increased T cell senescence
in the female genital tract does not appear to be a hallmark
of genital mucosal responsiveness to HIV-1 infection.Acknowledgments
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